Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog

被引:157
作者
Leong, CC
Chapman, TL
Bjorkman, PJ
Formankova, D
Mocarski, ES
Phillips, JH
Lanier, LL
机构
[1] DNAX Inst Mol & Cell Biol, Dept Immunol, Palo Alto, CA 94304 USA
[2] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA
[3] Stanford Univ, Dept Immunol Microbiol, Stanford, CA 94305 USA
关键词
cytomegalovirus; class I major histocompatibility complex; UL18; natural killer cell; cytotoxicity;
D O I
10.1084/jem.187.10.1681
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells have been implicated in early immune responses against certain viruses, including cytomegalovirus (CMV). CMV causes downregulation of class I major histocompatibility complex (MHC) expression in infected cells; however, it has been proposed that a class I MHC homolog encoded by CMV, UL18, play act as a surrogate ligand to prevent NK cell lysis of CMV-infected cells. In this study, we examined the role of UL18 in NK cell recognition and lysis using fibroblasts infected with either wild-type or UL18 knockout CMV virus, and by using cell lines transfected with the UL18 gene. In both systems, the expression of UL18 resulted in the enhanced killing of target cells. We also show that the enhanced killing is due to both UL18-dependent and -independent mechanisms, and that the killer cell inhibitory receptors (KIRs) and CD94/NKG2A inhibitory receptors for MHC class I do not play a role in affecting susceptibility of CMV-infected fibroblasts to NK cell-mediated cytotoxicity.
引用
收藏
页码:1681 / 1687
页数:7
相关论文
共 32 条
  • [11] GENERAL ROLE OF HLA CLASS-I MOLECULES IN THE PROTECTION OF TARGET-CELLS FROM LYSIS BY NATURAL-KILLER-CELLS - EVIDENCE THAT THE FREE HEAVY-CHAINS OF CLASS-I MOLECULES ARE NOT SUFFICIENT TO MEDIATE THE PROTECTIVE EFFECT
    CICCONE, E
    PENDE, D
    NANNI, L
    DIDONATO, C
    VIALE, O
    BERETTA, A
    VITALE, M
    SIVORI, S
    MORETTA, A
    MORETTA, L
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (03) : 393 - 400
  • [12] A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
    Colonna, M
    Navarro, F
    Bellon, T
    Llano, M
    Garcia, P
    Samaridis, J
    Angman, L
    Cella, M
    LopezBotet, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) : 1809 - 1818
  • [13] A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
    Cosman, D
    Fanger, N
    Borges, L
    Kubin, M
    Chin, W
    Peterson, L
    Hsu, ML
    [J]. IMMUNITY, 1997, 7 (02) : 273 - 282
  • [14] FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9
  • [15] FARREL H, 1997, NATURE, V386, P446
  • [16] HO M, 1982, EPIDEMIOLOGY CYTOMEG, P77
  • [17] SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY
    KARRE, K
    LJUNGGREN, HG
    PIONTEK, G
    KIESSLING, R
    [J]. NATURE, 1986, 319 (6055) : 675 - 678
  • [18] LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1
  • [19] Lanier L L, 1995, Semin Immunol, V7, P75, DOI 10.1006/smim.1995.0011
  • [20] SPECIFICITY OF HLA CLASS-I ANTIGEN RECOGNITION BY HUMAN NK CLONES - EVIDENCE FOR CLONAL HETEROGENEITY, PROTECTION BY SELF AND NON-SELF ALLELES, AND INFLUENCE OF THE TARGET-CELL TYPE
    LITWIN, V
    GUMPERZ, J
    PARHAM, P
    PHILLIPS, JH
    LANIER, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) : 1321 - 1336